Pomerantz To Rep Investors In Acadia Drug Deaths Case
Pomerantz LLP has been appointed as lead counsel in a proposed securities fraud class action alleging Acadia Pharmaceuticals Inc. inflated its stock price by hiding safety risks and downplaying reports of...To view the full article, register now.
Already a subscriber? Click here to view full article